Loading
Machine Learning in Bioinformatics · Journal article
Journal of Chemical Information and Modeling · August 17, 2026
Raises a question worth testing. It does not answer one.
FragSyn is a novel deep learning framework that predicts synergistic versus antagonistic drug combinations by decomposing drugs into molecular fragments and incorporating cell line context. The method achieves high in silico classification performance (AUC 0.944) on retrospective datasets, but this is a computational tool development study without prospective validation, experimental confirmation, or clinical translation.
Computational method development with retrospective validation. Drug pairs and cell line contexts from retrospective datasets; specific dataset sources and eligibility criteria not stated.. Intervention: FragSyn framework: molecular fragment decomposition, graph isomorphism network learning, cell-line-conditioned gating, and multisource feature fusion. Compared with: Eight baseline models (identities not specified in abstract).
FragSyn achieves AUC of 0.944 on the primary validation task Area under precision-recall curve (AUPR) of 0.942 reported Accuracy (ACC) of 0.872 achieved
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This is a computational tool paper. It may inform future drug combination screening pipelines, but clinical utility requires prospective experimental validation and clinical trials of predicted combinations.
This is a computational method development study with in silico validation on existing datasets; it does not report clinical outcomes, prospective validation, or experimental confirmation of predicted synergies.
As stated by the source record.
Quoted from the source exactly as published.
This is a computational tool paper. It may inform future drug combination screening pipelines, but clinical utility requires prospective experimental validation and clinical trials of predicted combinations.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Abstract Drug combination therapy plays an increasingly important role in the clinical treatment of complex diseases, such as cancer, as rational drug combinations can enhance therapeutic efficacy and reduce toxic side effects. However, existing methods still exhibit limitations in the granularity of drug molecular representation, drug interaction modeling, and cell line context awareness, which restrict further improvements in predictive performance. To address these issues, we propose FragSyn, a deep graph learning framework for predicting synergistic drug combinations based on molecular fragmentations. FragSyn first decomposes drug molecules into chemically meaningful fragments according to breaks of retrosynthetically interesting chemical substructure rules and learns fragment-level molecular representations through a graph isomorphism network with edge features. It then captures nonlinear relationships between drug pairs from multiple perspectives while introducing a gating modulation mechanism conditioned on cell line features, enabling drug representations to adapt dynamically to the cell line context. Finally, multisource features are fused to perform binary classification of synergy versus antagonism. FragSyn achieves AUC, AUPR, and ACC of 0.944, 0.942, and 0.872, respectively, outperforming eight baseline models, and demonstrates optimal generalization performance in both leave-one-out cross-validation and external validation. Ablation studies and interpretability analyses further validate the rationality of FragSyn and its ability to identify key fragments. These results indicate that FragSyn, through the synergistic design of fragment-level representation and cellular context awareness, provides an effective and interpretable new approach to synergistic drug combination prediction.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.